|
Volumn 11, Issue 6, 2003, Pages 729-732
|
A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C.
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
HEMOGLOBIN;
ICOSAPENTAENOIC ACID;
RIBAVIRIN;
ADULT;
ANEMIA;
ARTICLE;
BLOOD;
CHEMICALLY INDUCED DISORDER;
FEMALE;
HEPATITIS C;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
PILOT STUDY;
RETICULOCYTE COUNT;
ADULT;
ANEMIA;
ANTIVIRAL AGENTS;
EICOSAPENTAENOIC ACID;
FEMALE;
HEMOGLOBINS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
RETICULOCYTE COUNT;
RIBAVIRIN;
MLCS;
MLOWN;
|
EID: 1542600387
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.11.6.729 Document Type: Article |
Times cited : (15)
|
References (0)
|